Prostarm Info Systems Submits Revised Monitoring Agency Report for Q4 FY2025

Prostarm Info Systems Limited has filed a revised Monitoring Agency Report for the quarter ended March 31, 2026 (Q4 FY2025-26), pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. The report was prepared by Acuité Ratings and Research Limited, the appointed Monitoring Agency, to oversee the utilization of proceeds from the company's Initial Public Offering. The company clarified that the revised submission was necessitated by the inadvertent attachment of an unsigned copy in the earlier intimation, and that the contents of the report remain unchanged.

IPO Issue Overview

The company, which operates in the Other Electrical Equipment / Capital Goods sector, conducted its public issue during May 27, 2025 to May 29, 2025. The key details of the issue are summarized below:

Parameter: Details Issue Period: May 27, 2025 to May 29, 2025 Type of Issue: Public Issue Type of Securities: Equity Shares Issue Size: INR 168.000 Cr. Monitoring Agency: Acuité Ratings and Research Limited

Utilization of IPO Proceeds

The Monitoring Agency reviewed the deployment of IPO proceeds across all stated objects as at the end of Q4 FY2025-26. The report indicates that the majority of funds have been fully utilized, with one object remaining pending. The following table captures the progress in utilization:

Item Head: Amount Proposed [INR Cr.] Amount Raised [INR Cr.] Utilized at End of Quarter [INR Cr.] Unutilized [INR Cr.] Funding working capital requirements: 72.500 72.500 72.500 Nil Prepayment/repayment of outstanding borrowings: 17.958 17.958 17.958 Nil Inorganic growth through unidentified acquisitions & strategic initiatives: 12.483 12.483 - 12.483 General Corporate Purposes: 42.000 42.000 42.000 Nil Issue Expense: 23.059 23.059 23.059 Nil Total: 168.000 168.000 155.517 12.483

General Corporate Purpose Utilization

The INR 42.000 Cr. allocated under General Corporate Purposes was fully utilized by the end of the quarter. The breakdown of its deployment is as follows:

Item Head: Amount [INR Cr.] For Working Capital: 28.81 For Capacity Expansion: 13.19 Total: 42.000

The Monitoring Agency confirmed that the company had fully utilized the funds allocated towards these objects.

Delay in Inorganic Growth Object and Deployment of Unutilized Funds

A delay of 43 days (as on the Monitoring Agency report date) was noted in the implementation of the inorganic growth object, which had a completion date of March 31, 2026, as per the offer document. The object is yet to start. The Board of Directors stated that despite a detailed evaluation of domestic and international acquisition opportunities, no opportunity was identified that met the company's desired strategic and financial parameters, resulting in the temporary non-utilization of these funds.

The INR 12.483 Cr. in unutilized proceeds has been deployed in fixed deposits, as detailed below:

Instrument & Account: Amount Invested [INR Cr.] Maturity Date Earning [INR Cr.] Return on Investment (%) Market Value at End of Quarter [INR Cr.] Fixed Deposit – ICICI Bank (280213015400): 5.403 09-12-2026 0.011 6.25 5.51 Fixed Deposit – ICICI Bank (280213015399): 6.000 09-12-2026 0.012 6.25 6.12 Fixed Deposit – ICICI Bank (280213015413): 1.080 11-06-2027 0.002 6.40 1.10 Total: 12.483 0.025 12.73

The company's management has proposed redeployment of the unutilized IPO proceeds towards funding working capital requirements and is in the process of seeking requisite shareholder approval for the same. The Board noted that any future inorganic growth or strategic opportunities will be considered for funding through internal accruals or other permissible sources.

Monitoring Agency Findings

The Monitoring Agency, Acuité Ratings and Research Limited, confirmed that no material deviation from the objects of the issue was observed, and no change in the means of finance was noted. Key findings from the compliance review are summarized below:

Deviation from objects: No deviation observed

Material deviation requiring shareholder approval: Not applicable

Change in means of finance: No change observed

Favorable/unfavorable events affecting viability: None observed

Government/statutory approvals: Not required for the stated objects

Information materially affecting investor decision-making: None evident

The report was signed by Vikas Mishra, Deputy Vice President – Process Excellence, Acuité Ratings and Research Limited, and submitted on behalf of Prostarm Info Systems by Sachin Gupta, Company Secretary and Compliance Officer (Membership No: F12500).

Prostarm Info Systems Limited has submitted its annual disclosure to BSE Limited and the National Stock Exchange of India Limited, in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011. The filing, dated April 03, 2026, was submitted by Company Secretary and Compliance Officer Sachin Gupta and covers the financial year ended March 31, 2026.

Promoter Shareholding and Encumbrance Status

The declaration was made on behalf of the promoters and promoter group of Prostarm Info Systems Limited by promoter Ram Agarwal, signed at Mahape, Navi Mumbai on April 03, 2026. The filing confirms that the promoter and promoter group, including persons acting in concert, have not created any encumbrance — either directly or indirectly — on their shareholding in the company during the financial year ended March 31, 2026.

The key details of the promoter shareholding covered under this disclosure are as follows:

Parameter: Details Total Promoter & Promoter Group Shares: 4,28,74,592 equity shares Promoter Shareholding (%): 72.82% Encumbrance During FY: Nil Financial Year Covered: Year ended March 31, 2026 Date of Filing: April 03, 2026 Place of Signing: Mahape, Navi Mumbai

Regulatory Compliance

The disclosure has been filed pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011, which mandates promoters and promoter groups of listed companies to submit an annual declaration regarding the encumbrance status of their shareholding. The filing has been addressed to both BSE Limited and the National Stock Exchange of India Limited, and a copy has been marked to the Chairperson of the Audit Committee of Prostarm Info Systems Limited.

The compliance filing was signed and submitted by Sachin Gupta, Company Secretary and Compliance Officer (Membership No: F12500), on behalf of Prostarm Info Systems Limited.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.